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Abstract
The majority of bacterial infections occur across wet-surfaced mucosal epithelia, including those that cover the eye, respiratory
tract, gastrointestinal tract and genitourinary tract. The apical surface of all these mucosal epithelia is covered by a heavily
glycosylated glycocalyx, a major component of which are membrane-associated mucins (MAMs). MAMs form a barrier that
serves as one of the first lines of defense against invading bacteria. While opportunistic bacteria rely on pre-existing defects or
wounds to gain entry to epithelia, non opportunistic bacteria, especially the epidemic disease-causing ones, gain access to
epithelial cells without evidence of predisposing injury. The molecular mechanisms employed by these non opportunistic
pathogens to breach the MAM barrier remain unknown. To test the hypothesis that disease-causing non opportunistic bacteria
gain access to the epithelium by removal of MAMs, corneal, conjunctival, and tracheobronchial epithelial cells, cultured to
differentiate toexpressthe MAMs, MUCs1,4,and 16, were exposed toa non encapsulated,non typeable strain ofStreptococcus
pneumoniae (SP168), which causes epidemic conjunctivitis. The ability of strain SP168 to induce MAM ectodomain release from
epithelia was compared to that of other strains of S. pneumoniae, as well as the opportunistic pathogen Staphylococcus aureus.
The experiments reported herein demonstrate that the epidemic disease-causing S. pneumoniae species secretes a
metalloproteinase, ZmpC, which selectively induces ectodomain shedding of the MAM MUC16. Furthermore, ZmpC-induced
removal of MUC16 from the epithelium leads to loss of the glycocalyx barrier function and enhanced internalization of the
bacterium. These data suggest that removal of MAMs by bacterial enzymes may be an important virulence mechanism
employed by disease-causing non opportunistic bacteria to gain access to epithelial cells to cause infection.
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Introduction
A characteristic feature of all wet-surfaced mucosal epithelia of
the body is the presence of mucins on their apical surface that
separate underlying epithelial cells from the external milieu.
Mucins are a family of high molecular weight, O-glycosylated
proteins that can be classified as either secreted or membrane-
associated based on their molecular structure. Secreted mucins,
produced by goblet cells, occupy the uppermost, extensively
hydrated mucus coating that is moved over the epithelium and
functions primarily to sweep away trapped foreign material. On
the other hand, membrane-associated mucins (MAMs) anchored
to the apical epithelial cell membrane by their single transmem-
brane domain [1] form an extensively O-glycosyated glycocalyx
that serves as a barrier [2,3] and prevents commensal microbes
from adhering to the epithelium [3]. In addition, the short
cytoplasmic tail of some MAMs has been demonstrated to be
involved in signal transduction pathways [4,5].
The expression, distribution, biophysical properties, and functions
of MAMs vary depending on the type of host mucosal epithelium in
question. In humans, MAMs MUCs 1 and 4 are expressed
universally across mucosal epithelia; MUCs 3A, 3B, 11, and 12
are expressed by gut epithelia; and MUC16 is expressed by ocular
surface, respiratory tract, and the female reproductive tract epithelia
[6]. MUC16 is the largest known MAM, with a molecular weight of
.200 kDa [5]. When extended, its extracellular domain has been
estimated to protrude up to 500 nm from the epithelial surface [7,8].
Although there has been speculation that MAMs play an
important role in host defense against infectious agents by
providing a barrier against invading pathogens, the only data
available comes from studies of Muc1
2/2 mice (mucins in humans
are designated as MUC and those in mice as Muc). Muc1
2/2 mice
were shown to be at increased risk of chronic infection as well as
inflammation of the reproductive tract [9] and the ocular surface
[10] in comparison to wild type mice. Later studies showed that
the intestinal pathogen Campylobacter jejuni is capable of enhanced
colonization, rapid passage across the gastrointestinal barrier, and
induction of epithelial cell damage in Muc1
2/2 mice [11].
Similarly, Muc1 was found to limit acute and chronic colonization
by the gastritis-causing pathogen Helicobacter pylori [12].
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32418Little information is available on the role of MUC16 in host
defense. Recent data demonstrated that MUC16 expressed at the
human ocular surface possesses barrier functions [3,13,14].
Specifically, MUC16 prevents adhesion of the opportunistic
pathogen Staphylococcus aureus in human corneal epithelial (HCLE)
cells [3]. Observations of the anti-adhesive, barrier properties of
MUC16 at the epithelial surface raise an important question about
the ability of non opportunistic pathogens, especially the epidemic
disease-causing ones, to breach the MAM glycocalyx barrier and
trigger infection. To address this question and to characterize
mechanisms employed by such pathogens, the ability of an
epidemic conjunctivitis-causing, non encapsulated, non typeable
strain of S. pneumoniae and other strains of S. pneumoniae, as well as
the opportunistic pathogen S. aureus to manipulate the MAM
barrier was compared. Data presented in this manuscript show
that the epidemic disease-causing species of S. pneumoniae secretes a
zinc metalloproteinase, ZmpC, that selectively induces ectodomain
shedding of MUC16 and that the removal of MUC16 compro-
mises MAM glycocalyx barrier function, enhancing internalization
of the bacterium.
Results
Growth culture filtrates of S. pneumoniae strain SP168
and serotype 11A induce MUC16 shedding from
epithelial cells
To determine if clinical isolates of S. pneumoniae,b o t he p i d e m i c
(strain SP168) and non-epidemic (serotypes 1, 3, 8 and 11A), as
well as the laboratory strain R6, or whether the opportunistic
pathogen S. aureus alter the MUC16 glycocalyx barrier in
epithelial cells, human corneal (HCLE), conjunctival (HCjE),
and tracheobronchial (TrBr) cells cultured for optimal mucin
production [15] were treated with bacterial growth culture
filtrates for 1 or 4 hours. Material released into the cell culture
supernatants were analyzed by western blotting using a MUC16
ectodomain-recognizing antibody, M11 [16], as well as antibod-
ies to MUC1 and MUC4, 214D4 [17,18] and 8G7 [19],
respectively. Western blot analyses indicated that only bacterial
culture filtrates from strain SP168, which causes epidemic
conjunctivitis, and serotype 11A, which has been associated with
conjunctivitis [20] and pneumonia [21], induced MUC16
ectodomain release (Figure 1A, B). This MUC16 ectodomain
release from HCLE, TrBr, and HCjE cells by the growth culture
filtrate derived from strain SP168 was found to be higher than
that induced by the filtrate from serotype 11A. Follow-up
experiments have indicated that the zmpC gene in strain SP168,
which is truncated, encodes a more potent zinc metalloproteinase
(Menon B. B., et al., manuscript in preparation). A small and
variable amount of constitutive release of the MUC16 ectodo-
main was occasionally observed, especially from the ocular
surface epithelial cell types (HCLE and HCjE). This phenomenon
of constitutive release of the MUC16 ectodomain from ocular
surface epithelial cells has been previously reported [22,23,24];
however, little is known about the innate mechanism(s) associated
with constitutive MUC16 ectodomain release. Lack of binding of
a MUC16 cytoplasmic tail antibody [23] to the released mucin
demonstrates that the MUC16 in the culture media after
treatment with the SP168 culture filtrate is a result of ectodomain
release (Figure 2). No release of MUC16 ectodomain from the
epithelial cell surface was observed following treatment with
filtrates obtained from serotypes 1, 3, 8 and the laboratory strain
R6 (Figure 1A, B) or from S. aureus (Figure 1C, D). The induction
of MUC16 shedding was selective, in that MAMs MUCs 1 and 4
were not released by growth culture filtrates derived from strain
SP168 (Figure S1 A, B).
The amount of MUC16 on the epithelial cell surface is
significantly reduced by the SP168 growth culture filtrate
The efficiency of the SP168 growth culture filtrate to remove
the MUC16 ectodomain was determined by assaying the amount
of residual MUC16 on the epithelial cell surface after treatment
with the filtrate. As assay, epithelial cells were exposed to
bacterial growth culture filtrates, followed by biotinylation of the
epithelial cell surface proteins. Prior to biotinylation, cell culture
supernatants were recovered from the HCLE cells treated with
medium only as control or SP168 growth culture filtrate samples,
for analysis of amount of released MUC16 protein. Western blot
analyses were performed on samples of biotinylated cell surface
MUC16 and released MUC16 ectodomain (Figure 3A). Treat-
ment of epithelial cells with the SP168 growth culture filtrate
resulted in a 56% decrease in surface abundance of MUC16
after 1 hour of exposure compared to total MUC16 levels
(Figure 3B).
The MUC16 sheddase secreted by S. pneumoniae is a zinc
metalloproteinase, ZmpC
Preliminary experiments demonstrated that both heat inactiva-
tion and treatment with proteinase k, eliminate the sheddase
activity in the SP168 growth culture filtrate, indicating that the
sheddase is a protein (data not shown). Since S. pneumoniae strains
are known to secrete metalloproteinases [25], SP168 growth
culture filtrates were treated with metalloproteinase inhibitors
GM6001 or TAPI-1 [26]. Filtrates treated with the metallopro-
teinase inhibitors showed a reduction of MUC16 ectodomain
release compared to the medium only control (Figure S2). Thus,
the protein of interest was predicted to be a secreted metallopro-
teinase.
T oi d e n t i f yt h es h e d d a s ei nt h eS P 1 6 8g r o w t hc u l t u r ef i l t r a t e ,
conventional protein purification methods were used, including
filtration with a 50 kDa cutoff concentrator, followed by DEAE
anion exchange, then size exclusion chromatography (SEC)
(Figure 4 A, B). Peak sheddase activity was found between
fractions 5–9 and 7–12, collected from the DEAE column and
from SEC, respectively; the activity was determined by exposing
HCLE cells to the different fractions that had been separated by
chromatography and monitoring the fractions that induced
maximal MUC16 ectodomain release. Of the fractions that
exhibited peak MUC16 sheddase activity, fraction 9 of the SEC
showed the maximum amount of total protein and was thus
separated by SDS-PAGE and stained with GelCode blue. Three
distinct bands, observed at ,180 kDa, ,170 kDa and ,50 kDa
(Figure 4B), were subjected to mass spectrometric analysis,
which identified them as ZmpC (Table 1). The different
molecular weights observed on the gel may represent cleavage
products of ZmpC, as previously suggested by Chen et al. 2007
[26].
The SP168 deletion mutant (zmpCD) fails to induce
MUC16 shedding in epithelial cells
To verify that ZmpC is the MUC16 sheddase, a mutant strain
was constructed from SP168 in which the zmpC gene was deleted
and replaced with an erythromycin resistance cassette [27].
Epithelial cells were treated with culture medium, which served
as control, or bacterial growth culture filtrates obtained from
strains R6, which lacks the zmpC gene [28], wild type SP168, or its
zmpCD mutant. In striking contrast to MUC16 shedding following
A Bacterial Protease Induces MUC16 Shedding
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growth culture filtrate obtained from the zmpCD mutant resulted in
no MUC16 ectodomain release (Figure 5 A, B). These results
confirm findings from mass spectrometric analysis, which
indicated ZmpC as the MUC16 sheddase. Further evidence that
ZmpC is indeed the MUC16 sheddase came from the finding that
only those S. pneumoniae serotypes containing the zmpC gene
induced MUC16 ectodomain shedding (Figures 1A and 6).
Figure 1. Epithelial MUC16 release by growth culture filtrates from different S. pneumoniae species and S. aureus.A ) Western blots
using M11, a MUC16 ectodomain-specific antibody, on culture supernatants of HCLE, TrBr, and HCjE cells after exposure to growth culture filtrates
from S. pneumoniae strains R6 and SP168, and serotypes 1, 3, 8, and 11A. The 250 kDa standard marker is indicated on the left. B) Quantitative
analyses of the western blots in (A) demonstrated that bacterial culture filtrates from only SP168 and serotype 11A induced release of the MUC16
ectodomain (n=3). C) Western blot with the M11 antibody, on culture supernatants of HCLE cells after exposure to growth culture filtrates from S.
pneumoniae strain SP168 and S. aureus ALC1435. D) Quantitative analysis of the western blot in (C) shows the inability of growth culture filtrate
derived from S. aureus to induce MUC16 ectodomain shedding (n=3). Data represent MUC16 units relative to the standard 6 standard error of the
mean (SEM). E) Western blot using the M11 antibody on known, increasing amounts of a partially purified MUC16 isolate. F) A standard curve that
was generated by plotting band intensities that were in the linear range (E) vs known amounts of partially purified MUC16 protein.
doi:10.1371/journal.pone.0032418.g001
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SP168 growth culture filtrate compromises the
glycocalyx barrier
Degree of penetrance of rose bengal, an anionic dye, is an
established method of assaying epithelial barrier function
[3,14,29]. It has previously been demonstrated that corneal
epithelial cells exclude this dye [14], and that siRNA knockdown
of MUC16 in these cells leads to increased uptake of the dye that
in turn is associated with increased pathogen adherence [3]. It has
also been reported that abrogation of O-glycosylation of MAMs in
the glycocalyx and their association to galectin-3 lead to the loss of
barrier function, as indicated by rose bengal dye penetrance [13].
To test if ZmpC-induced removal of MUC16 from the corneal
epithelial surface results in loss of glycocalyx barrier function,
HCLE cells were cultured with growth culture filtrates derived
from strain SP168 for 4 hours, followed by staining of the
epithelial cell surface with rose bengal dye. HCLE cells treated
with the SP168-derived growth filtrate exhibited a statistically
significant 20% increase in rose bengal dye penetrance in
comparison to the control medium only-treated HCLE cells
(Figure 7). These results indicate that removal of the MUC16
ectodomain by ZmpC diminishes glycocalyx barrier function.
Strain SP168 invades stratified epithelial cells more
efficiently than its isogenic zmpC deletion mutant
(zmpCD)
To determine if the epidemic conjunctivitis-causing bacteri-
um SP168 is able to invade the epithelial cells, a bacterial
internalization assay was performed. Epithelial cells grown for
optimal mucin production were cultured with SP168 bacteria
or the SP168 zmpCD mutant for 4 hours. An antibiotic
protection assay was used to determine the numbers of
internalized bacteria [30]. A 2-fold, statistically significant
difference was observed between the number of internalized
bacteria with the SP168 strain compared to the zmpCD mutant
Figure 3. Apical cell surface abundance of MUC16 is reduced
following treatment of epithelia with SP168 growth culture
filtrate. Apical membrane levels of MUC16 were determined by cell
surface biotinylation. A) Western blot analyses (using M11 antibody) of
the amount of released and residual biotin-labeled surface MUC16 after
exposure to medium only control or SP168 growth culture filtrate. B)
Quantitative analyses of the western blot in (A) showing a reduction in
the abundance of surface MUC16 following treatment with the SP168
culture filtrate (p,0.0001, Student’s t-test, n=3). Data for MUC16
surface abundance is expressed as a percentage of the total released
plus surface MUC16 6 SEM.
doi:10.1371/journal.pone.0032418.g003
Figure 2. MUC16 released from epithelial surfaces by SP168
does not bind to a MUC16 cytoplasmic tail antibody indicating
ectodomain release. HCLE cells were cultured with growth culture
filtrate obtained from strain SP168 for 1 hour (SP168), and the resultant
media was diluted 1:3 with DMEM/F12, and subjected to a 10 kDa
cutoff concentrator. HCLE cell lysate with intact full-length MUC16
(75 mg) was used as a positive control. Western blot of the resulting
concentrate and cell lysate using: A) MUC16CT antibody that
recognizes full-length MUC16 at .250 kDa and the cytoplasmic tail
between 25–37 kDa, or B) MUC16 extracellular domain (ECD) antibody
(M11). The MUC16CT antibody binds to the positive control cell lysate
only (arrow), but not to the cell culture supernatants after exposure to
SP168 (A). Conversely, M11 antibody binds to a band of appropriate
molecular weight in culture supernatants as well as the cell lysate (B).
These data indicate that the sheddase releases the MUC16 ectodomain
into the cell culture media. Molecular weight standards are on the left in
kDa.
doi:10.1371/journal.pone.0032418.g002
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invade corneal epithelial cells as a result of exposure to the
bacteria. Since cell invasion is a well-established process of
infection, these experiments indicate that a loss in the levels of
apical MUC16 on the epithelial barrier enhances internaliza-
tion, thus infection.
Discussion
In order for disease-causing, non opportunistic bacteria, to
infect mucosal tissues, they must cross the MAM glycocalyx
barrier that normally prevents adherence of opportunistic bacteria
to epithelial surfaces [3,11,12]. Data provided herein describe for
Figure 4. Isolation of the MUC16 sheddase and its identification as ZmpC. MUC16 sheddase-enriched fractions were isolated first by DEAE
chromatography, with concentrations of sodium chloride eluent shown in the figure on the right (A), then by size exclusion chromatography (B). A
sample from fraction 9 (indicated by an arrow) in B was separated by SDS-PAGE and stained using GelCode Blue stain. The 3 bands observed at
,180 kDa, ,170 kDa and ,50 kDa were analyzed by mass spectrometry. Numbers on the left of the gel indicate molecular weight standards in kDa.
The Y axes of graphs in (A) and (B) represent the net intensities corresponding to MUC16 signal on western blots. Constitutive MUC16 ectodomain
release was observed in fractions whose net intensities correspond to that of the control. The mechanism(s) associated with constitutive MUC16
ectodomain shedding remains unknown.
doi:10.1371/journal.pone.0032418.g004
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non opportunistic, infection-causing bacterium, S. pneumoniae,t o
compromise the MAM glycocalyx barrier to gain entry into the
epithelium. We have identified and confirmed that a zinc
metalloproteinase, ZmpC, secreted by certain virulent strains of
S. pneumoniae, directly targets and induces ectodomain shedding of
MUC16, a crucial defense component of the epithelial MAM
glycocalyx barrier.
Bacterial extracellular zinc metalloproteinases have long been
regarded as important contributors to the virulence of several
pathogens [31]. S. pneumoniae secretes three zinc metalloproteinases
including IgA1, ZmpB, and ZmpC [25]. These metalloproteinases
contain the canonical zinc-binding motif HEXXH [31] and the
highly conserved, prototypical LPXTG sequence of gram-positive
cell surface proteins [32]. Intriguingly, they share very little
homology at the primary amino acid sequence level. Of the three
metalloproteinases, IgA1 has been the most extensively studied
enzyme, and its role in pathogen virulence has been well
documented [33,34]. While the biological role of ZmpB remains
unknown, ZmpC has been demonstrated to cleave the matrix
metalloproteinase MMP-9 and contribute to streptococcal viru-
lence in experimentally induced pneumonia [35], but the
mechanism of its action remains unclear. ZmpC has also been
shown to cause shedding of syndecan-1 from murine mammary
gland epithelial cells [26]; however, the mammary gland epithelial
surface does not represent a site easily accessible to mucosal
infection-causing pathogens.
In the present study, a novel function for ZmpC has been
discovered, in that the enzyme induces ectodomain shedding of
the MAM MUC16 from epithelial cell surfaces – a finding
supported by multiple lines of investigation. Using protein
purification methods and mass spectrometric analyses, the enzyme
in the SP168 growth culture filtrate that induces MUC16
ectodomain shedding from epithelial surfaces was identified as
ZmpC. Furthermore, we showed that a zmpC deletion mutant
(zmpCD), isogenic to strain SP168, is not capable of inducing
MUC16 ectodomain shedding from epithelial surfaces. Finally, we
found that only those strains of S. pneumoniae that induce MUC16
ectodomain shedding in HCLE, HCjE, and TrBr cells contain the
zmpC gene. Demonstration that ZmpC is a sheddase specific for
MUC16 may be most relevant to its potential virulence factor
activity in pneumonia and conjunctivitis, since the tracheobron-
chial and ocular surface epithelia express high levels of the MAMs
on their mucosal surfaces [15,36].
MAMs, which form a major component of the glycocalyx on
the apical surfaces of mucosal epithelia, where they can extend up
to 500 nm from the epithelial surface [8], have been demonstrated
to provide a barrier to pathogen and cell adherence
[3,11,12,37,38]. Removal of the MAM MUC16 from epithelial
surfaces by ZmpC secreted by certain strains of S. pneumoniae
abrogates barrier function, as indicated by penetrance of rose
bengal dye normally excluded from the epithelial cells [3,14] and,
importantly, internalization of the bacterium into the epithelial
cell. Moreover, it has been previously shown that S. pneumoniae
strain SP168 adheres to epithelial cells under culture conditions
that do not promote mucin expression [37]. Taken together, these
data suggest that epidemic infection-causing bacteria have the
potential to manipulate the MAM barrier to gain access to
epithelial surfaces.
Definitive proof that ZmpC is a virulence factor for
conjunctivitis and pneumonia in vivo through its sheddase activity
for MUC16, awaits the development of an appropriate animal
model. Development of such a model is complicated by the fact
that, while there are MAM homologues in the mouse, their size,
glycosylation characteristics and, most importantly, their epithe-
lial distribution is quite different than in human. For example,
unlike in the human, Muc16 is not found in mouse ocular
surface or reproductive tract epithelia [39]. While MUC16 is
present in both mouse and human tracheobronchial epithelia,
the mucins’ structures vary dramatically, with a 258 aa length
and single SEA module in the mouse, as compared to a 22,152
aa length and 56 SEA modules in human [40]. Moreover,
MUC16’s role in glycocalyx barrier formation in the mouse is
not known. Perhaps the well-known cross species differences in
susceptibility to bacterial infections [41] is influenced by the
variability in character of glycocalyx membrane mucins among
species.
It should be noted that Oggioni et al. have demonstrated that a
zmpCD pneumococcus, constructed in strain FP23, shows a
decrease in virulence in a mouse model for pneumonia [35].
These authors related the virulence to ZmpC-mediated cleavage
of the proform of MMP-9 to activate the metalloproteinase. It is
not known however, if MMP-9 plays a role in MUC16
ectodomain release in epithelial cells.
An alternative or additional explanation regarding consequenc-
es of MUC16 shedding from epithelial surfaces in response to
ZmpC is that the released MUC16 ectodomain serves as a ‘decoy
ligand’ [2,11] for adhesins expressed on the cell surface of S.
pneumoniae, preventing the pathogen from docking to the epithelial
cell membrane. Following release of the MUC16 ectodomain,
signaling by the MUC16 cytoplasmic tail could, in turn,
potentially invoke an inflammatory response to clear the invading
Table 1. Mass spectroscopic analysis of the purified SP168 sheddase identified as metalloproteinase ZmpC.
Band number Protein Peptide matches % sequence coverage
1 ,180 kDa Zinc metalloproteinase ZmpC 126 59.8%
Immunoglobulin A1 protease 13 7.3%
Immunoglobulin A1 11 7.1%
2 ,170 kDa Zinc metalloproteinase ZmpC 141 62.2%
Immunoglobulin A1 protease 15 7.3%
Immunoglobulin A1 protease 10 6.0%
3 ,50 kDa Zinc metalloproteinase ZmpC 66 42.7%
Glucose-6-phosphate isomerase 26 45.4%
Aminopeptidase C 21 41.4%
doi:10.1371/journal.pone.0032418.t001
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explored.
It remains to be seen if membrane mucin sheddases secreted by
bacteria are a common virulence factor used by other disease-
causing, non opportunistic bacteria. Since the repertoire of MAMs
expressed at different mucosal surfaces varies (e.g., gut epithelia
express MAMs MUCs 1, 3, 4, 11/12, and tracheobronchial/
ocular surface/female reproductive tract epithelia express MUCs
1, 4 and 16), it would be interesting to determine if different
membrane mucin sheddases act as virulence factors in gut
infections than in MUC16-expressing epithelia. Moreover, it
would be interesting to determine if the membrane mucin
sheddases facilitate secondary infections by opportunistic patho-
gens.
In summary, this is the first demonstration that metalloprotei-
nases secreted by non opportunistic bacteria can induce
ectodomain release of membrane-associated mucins. Loss of the
membrane mucin barrier compromises epithelial integrity and
promotes internalization of the bacteria to facilitate infection
(Figure 9).
Figure 5. Epithelial MUC16 ectodomain release is induced by growth culture filtrate from SP168 but not from the SP168 zmpCD
mutant. A) Western blots using M11 antibody comparing the amount of shed MUC16 in cell culture supernatants recovered after exposure of
stratified HCLE and TrBr cells to bacterial growth culture filtrates from strains R6, wild type SP168 and the SP168 zmpCD mutant. B) Quantitative
analyses of western blots in (A) show that the filtrate derived from the SP168 zmpCD mutant is unable to induce MUC16 ectodomain shedding in
HCLE cells as well as in TrBr cells (n=3). All data are represented as MUC16 units relative to the standard 6 SEM.
doi:10.1371/journal.pone.0032418.g005
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Ethics statement
As described previously for development and characterization of
the telomerase-transformed human corneal (HCLE) and human
conjunctival (HCjE) epithelial cell lines used in this study [15,42],
human corneal epithelial cells were derived from human
corneoscleral rims provided by Roger Steinert and Ann Bajarat
of Ophthalmic Consultants of Boston. Human conjunctival biopsy
specimens with normal ocular surfaces were provided by C. Steven
Foster of the Massachusetts Eye and Ear Infirmary. These samples
were obtained without patient identifiers as discarded tissue post
surgery.
Primary cultures of human tracheobronchial epithelial cells
were commercially obtained, without patient identifiers from
Clonetics (Lonza; Walkersville, MD). Research involving the study
of existing data, documents, records, pathological specimens, or
diagnostic specimens (source of tracheobronchial epithelial cells), if
these sources are publicly available and used in such a manner that
subjects cannot be identified, directly or through identifiers linked
to the subjects, is considered exempt from Institutional Review
Board (IRB) under HHS regulations at 45 CFR 46.101(b)(4).
Culture of human ocular surface cell lines
Telomerase immortalized human corneal (HCLE) and con-
junctival (HCjE) epithelial cells were cultured in keratinocyte
serum-free medium (Invitrogen, Carlsbad, CA) until confluence,
then switched to Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F-12 (DMEM/F12; Cellgro, Manassas, VA) supplement-
ed with 10% calf serum and 10 ng/mL epidermal growth factor
(EGF) for 7 days to promote differentiation, stratification and
optimal membrane mucin production [15].
Derivation and culture of tracheobronchial epithelial cell
line
Primary cultures of human tracheobronchial epithelial cells
obtained from Clonetics (Lonza) were immortalized by expression
of hTERT and abrogation of p16 and p53 function. Full details of
the techniques used for derivation of the cell line have been
reported [15,42].
Tracheobronchial epithelial cells were cultured and grown to
confluence in Bronchial Epithelial Cell Basal Medium (Clonetics,
Lonza) containing manufacturer recommended growth supple-
ments and then switched to 10% serum+10 ng/mL EGF-
containing DMEM/F12 medium for 7 days to promote optimal
mucin production. When grown on plastic, the tracheobronchial
cells express MUCs 1, 4 and 16 on the apical epithelial surface
(data not shown).
Bacterial growth culture filtrates
S. pneumoniae serotypes 1, 3, 8, 11A, R6, and strain SP168 were
obtained from the Centers for Disease Control and Prevention
(Atlanta, GA) and were routinely streaked and grown on 5% sheep
blood agar plates (Becton Dickinson; Franklin Lakes, NJ) [37].
Individual colonies from plates were inoculated in Todd-Hewitt
(TH) broth containing 0.5% w/v yeast extract and grown to an
OD595 of 0.22. Staphylococcus aureus strain ALC1435, a sarP1::gfp
derivative of RN6390 (gift of Dr. Ambrose L. Cheung, Dartmouth
College; Hanover, NH), was grown in brain heart infusion
medium (BHI; Research Products International; Mt. Prospect, IL)
to an OD595 of 0.4. All liquid cultures were grown under static
conditions, and all incubations were at 37uC with 5% CO2.T o
obtain bacterial growth culture filtrates, liquid cultures grown to a
density as indicated above were centrifuged at 40006 g for
10 minutes at RT. The resulting supernatants were filtered
through a 0.22 mm filter and stored at 280uC until the filtrates
were tested for MUC16 sheddase activity. The growth culture
filtrates were stable for at least 2 years at 280uC without freeze-
thaw.
Western blot analysis of membrane mucins in epithelial
culture medium after treatment of epithelial cell cultures
with bacterial growth culture filtrates
Cells were cultured in 24 well plates (1.9 cm
2/well) or 6 well
plates (9.5 cm
2/well). Cells were washed three times with 1 mL of
DMEM/F12 media prior to treatment with bacterial growth
culture filtrates. Epithelial cell cultures were treated with bacterial
growth culture filtrates or Todd-Hewitt broth (medium only
control) pre-diluted 1:1 with DMEM/F12 for 1 or 4 hours at 37uC
with 5% CO2. Cell culture supernatants were recovered after
filtration using a 0.22 mm filter. 500 mL of supernatants were
concentrated using a 10 kDa cutoff concentrator (Millipore; Cork,
Ireland). The retention volume was 25–30 mL. The 25–30 mL
Figure 6. zmpC is present only in certain strains of S.
pneumoniae. Genomic DNA isolated from all strains of S. pneumoniae
under study was subjected to polymerase chain reaction to screen for
the zmpC gene. Amplified products were separated on a 1% agarose/
TBE gel. Molecular weight markers are represented in kilobase pairs
(kbp). Products corresponding to the bands observed at ,5 kbp were
sequenced at the University of Maine DNA Sequencing Facility and
identified as zmpC. Data indicated that the zmpC gene was present in S.
pneumoniae strain SP168 and serotype 11A, the only strains exhibiting
MUC16 sheddase activity. zmpC from S. pneumoniae strain SP168 was
found to be 723 bp shorter than that of serotype 11A. The two
sequences are 86.5% identical.
doi:10.1371/journal.pone.0032418.g006
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e32418Figure 7. Rose bengal penetrance into HCLE cells increases after SP168 growth culture filtrate treatment. Brightfield micrographs were
taken of HCLE cells stained with rose bengal dye following exposure to (A) medium only control or (B) ZmpC-containing growth culture filtrate
obtained from strain SP168. Areas of cells with dye penetrance (p=0.01, Mann-Whitney test, n=55) were quantified using ImageJ software (C). Scale
bar=100 mm. These data indicate that the barrier efficiency of epithelial cells after exposure to ZmpC decreases due to loss of MUC16 ectodomain.
Increased dye penetrance has been shown previously with siRNA knockdown of MUC16 [3].
doi:10.1371/journal.pone.0032418.g007
Figure 8. S. pneumoniae strain SP168 invades epithelial cells more efficiently than its isogenic zmpCD mutant. HCLE cells were
incubated with SP168 and zmpCD mutant bacteria for 4 hours. Surface-bound bacteria were killed using an antibiotic protection assay. Quantitation
of number of internalized bacteria was performed by serial dilutions of lysed cells and back-plating on blood agar plates. Data are expressed as a
percentage of the number of bacteria recovered after the assay, divided by the initial inoculum number 6 SEM (p,0.0001, unpaired t-test, n=6).
doi:10.1371/journal.pone.0032418.g008
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and analyzed by SDS-agarose electrophoresis followed by
western blotting for MUC16 release using the M11 antibody
[16] (Neomarkers; Fremont, CA), which recognizes the ectodo-
main region of the molecule and with horseradish peroxidase-
conjugated goat anti-mouse IgG1 (Santa Cruz Biotechnology, sc-
2969; Santa Cruz, CA) as the secondary antibody. A MUC16
cytoplasmic tail-specific antibody, MUC16 CT [23] was used to
determine if the released mucin lacked its cytoplasmic tail. The
secondary antibody used in this blotting procedure was
horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa
Cruz Biotechnology, sc-2054). Western blot analyses for MUC1
and MUC4 ectodomain release were performed using the 214D4
antibody (Upstate Cell Signaling Technologies; Lake Placid, NY)
and 8G7 antibody (a gift from Dr. Surinder K. Batra; University
of Nebraska Medical Center) specific to the MUC1 and MUC4
ectodomains, respectively. Horseradish peroxidase-conjugated
goat anti-mouse IgG1 (Santa Cruz Biotechnology, sc-2969) was
used as the secondary antibody. Western blots were developed
using the SuperSignal West Femto Maximum Sensitivity
Substrate (Thermo Scientific; Rockford, IL). Band intensities on
blots were measured using the Kodak dS 1D digital science
software, version 2.02, from Kodak Imaging systems (New
Haven, CT).
Quantitation of relative amounts of MUC16 protein in samples
was done by extrapolation from a standard curve. This curve was
generated by running known amounts of a partially purified
MUC16 isolate, ranging from 0 mg to 5.0 mg, in parallel with
samples (Figure 1E, F). The partially pure fraction of MUC16,
which was used for plotting the standard curve, was isolated from
the ovarian adenocarcinoma cell line, NIH:OVCAR-3 (ATCC
HTB-161) [43], using the protocol described by Schultes, B. C. et
al. [44]. After separation of the proteins by SDS-agarose gel
electrophoresis and subsequent western blotting, a plot was
generated with band intensities on the Y axis and known amounts
of partially purified MUC16 protein on the X axis. Data points
that were within the linear range were used to generate the
standard curve, which relates the amount of protein to signals on
the blot. The slope-intercept form of the linear equation obtained
from the standard curve was used to quantitate the relative
amounts of MUC16 protein in samples. For instance, in Figure 1B,
the amount of MUC16 protein released from HCLE, TrBr, and
HCjE cells (Figure 1A) was calculated by substituting band
intensities obtained from samples for y values in the equation,
y=5698.2x24661.6 (Figure 1F).
Surface protein biotinylation
Stratified HCLE cells grown for optimal mucin production, as
described above, were treated with the SP168 growth culture
filtrate or medium control for 1 hour. Biotinylation of cell surface
proteins was performed as described [23]. Briefly, after the 1 hour
treatment, the cells were incubated with 500 mg/mL sulfo-NHS-
biotin (Pinpoint Cell Surface Protein Isolation kit, Pierce; Rock-
ford, IL) for 30 minutes at 4uC. Cells were lysed and biotinylated
cell surface proteins were isolated using NeutrAvidinTM gel.
Biotinylated proteins were eluted using 50 mM dithiothreitol. The
amount of surface biotinylated MUC16 remaining after treatment
with the SP168 growth culture filtrate is represented as a
percentage of the total cellular MUC16 (released MUC16 plus
surface MUC16).
Purification of the MUC16 sheddase from the SP168
growth culture filtrate
Initially, the SP168 growth culture filtrate (140 mL) was
subjected to 50 kDa cutoff concentration (Millipore) and 150 mL
was recovered as the retention volume. After testing for MUC16
sheddase activity on HCLE cells, 2 mg of protein from the
concentrated sample was resuspended in 1 mL of buffer (20 mM
Tris, 20 mM NaCl, pH 7.4) and subjected to anion exchange
chromatography using a HiTrap DEAE FF 5 mL column (GE
Healthcare; Piscataway, NJ). Fractions were collected using a
0.02–1 M NaCl gradient at a flow rate of 1 mL/minute. All
fractions were tested for MUC16 sheddase activity on HCLE cells.
Active fractions from 3 runs (protein concentration between 0.23–
0.43 mg/mL) of anion exchange chromatography, found to elute
between 150–300 mM NaCl, were pooled and subjected to a
10 kDa cut off concentrator. 0.8 mg of protein of the concentrat-
ed, pooled active fraction was diluted in 90 mL of elution buffer
(50 mM Tris, 50 mM NaCl, pH 7.4) and loaded onto a 4% cross-
linked, agarose bead (CL-4B) 10630 cm column with a 25 mL
bed volume. Fractions, eluted at a flow rate of 0.15 mL/minute,
were tested for MUC16 sheddase activity. Both ion exchange and
size exclusion chromatography were performed using a Dionex
Bio-LC chromatography system (Sunnyvale, CA). Protein con-
centrations were determined using micro BCA analysis (Pierce)
prior to and after each step of purification.
Mass spectroscopic analyses
Fractions with peak activity from size exclusion chromatogra-
phy were resolved by 10% SDS-PAGE and stained with GelCode
Figure 9. Diagram of the mechanism by which S. pneumoniae strain SP168 gains entry into epithelial cells. Scanning electron
micrograph of S. pneumoniae strain SP168 (A), which secretes a zinc metalloproteinase, ZmpC, onto the apical surface of the epithelia (B), which has a
glycocalyx rich in MUC16 transmembrane mucins that emanate from surface microridges (adapted from [47]). The secreted ZmpC induces MUC16
ectodomain release, causing a decrease in amount of MUC16 on the apical surface of the epithelium (C), that compromises the glycocalyx barrier
integrity. S. pneumoniae, depicted in orange, is thus able to invade the epithelial cells due to the loss of MUC16 (D).
doi:10.1371/journal.pone.0032418.g009
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,180 kDa, ,170 kDa, and ,50 kDa were excised and submitted
for MALDI-TOF analyses to the TAPLIN mass spectroscopy
facility, Harvard Medical School, Boston, MA.
Polymerase chain reactions to amplify zmpC
Presence of the zmpC gene in the different strains of S. pneumoniae
was determined by polymerase chain reaction (PCR). Primers
corresponding to the 59 and 39 regions of S. pneumoniae TIGR4
zmpC (GenBank: AAK74260.1) were used. Primer sequences are
listed in Table S1. Genomic DNA isolated from the different
strains [45] served as templates in reactions. Amplified products
were sequenced at the University of Maine DNA Sequencing
Facility to confirm the identity of zmpC.
Construction of the SP168 zmpC deletion mutant
(zmpCD) mutant
The SP168 zmpCD mutant was constructed by replacing the
zmpC gene of wild type SP168 with an erythromycin resistance
cassette (ermAM). Sequences that were identical to the 59 upstream
and 39 downstream regions of zmpC were fused to the ermAM
cassette on either side by overlap extension PCR to drive
homologous recombination. The replacement fragment, at a
concentration of 0.5 mg/mL, was used to transform SP168 cells
that were made competent using competence stimulating peptide
(CSP) [30,46]. Transformants were selected on casitone+tryptone
agar plates containing 0.25 mg/mL erythromycin [27]. The
correct zmpCD mutant was confirmed by PCR. Primers used in
the construction of the zmpCD mutant are listed in Table S1.
Rose bengal dye penetrance assay for determining
barrier integrity
Corneal epithelial cells (HCLE) were grown to stratification and
optimal mucin expression as described above. Cells were treated
with medium only control or SP168 growth culture filtrate for
4 hours. Cells were then washed 3 times with phosphate-buffered
saline (PBS), pH 7.4, followed by incubation for 5 minutes with
0.1% w/v rose bengal dye (Acros Organics; Morris Plains, New
Jersey) prepared in calcium/magnesium-free PBS. The dye was
then aspirated and cell cultures were photographed [3]. ImageJ
software (NIH) was used to quantify the areas of the cell cultures
that incorporated the rose bengal dye.
SP168 and zmpCD mutant internalization assay
Pneumococcal internalization assays were performed as de-
scribed by Pracht, D. et al. [30]. Briefly, HCLE cells were grown to
optimal mucin production and switched to antibiotic-free
stratification medium for 24 hours prior to the internalization
assay. Cells were then washed 3 times with DMEM/F12 medium;
next SP168 or zmpCD bacteria grown to an OD595 of 0.05–0.1 in
TH broth and diluted 1:1 in DMEM/F12 medium were added.
After incubation of the epithelial cultures for 4 hours with the
bacteria at 37uC/5% CO2, unbound bacteria were washed away
by rinsing the HCLE cell surface with DMEM/F12 medium.
Extracellular bound bacteria were killed by incubation of HCLE
cells with DMEM/F12 medium containing 100 mg/mL gentami-
cin and 100 U/mL penicillin G for 1 hour at 37uC. Cells were
then washed 3 times with sterile 16PBS and treated with 0.05%
trypsin-EDTA for 10 minutes at 37uC/5% CO2. Internalized
pneumococci were recovered by lysing the HCLE cells with 1%
w/v saponin prepared in DMEM/F12 medium. Serial dilutions of
epithelial cells containing internalized pneumococci were prepared
and plated on 5% sheep blood agar plates. Following 18–24 hour
incubation of the plates at 37uC/5% CO2, colony forming units
corresponding to the pneumococci were counted. The number of
the internalized bacteria is expressed as the number of
pneumococci recovered from the antibiotic protection assay
divided by the number of bacteria initially added to HCLE cells.
Supporting Information
Figure S1 HCLE cells do not release MUC1 and MUC4
ectodomain in response to S. pneumoniae growth
culture filtrates. Western blot analyses on culture supernatants
of HCLE cells after exposure to growth culture filtrates from S.
pneumoniae strain SP168 using the 214D4 antibody, which
recognizes the MUC1 ectodomain (A) or with 8G7 antibody,
which recognizes the MUC4 ectodomain (B). +Control=HCLE
cell lysate, control=medium exposure only, SP168=with SP168
growth culture filtrate.
(TIF)
Figure S2 Treatment of the SP168 culture filtrate with
matrix metalloproteinase inhibitors decreases its ability
to induce MUC16 shedding from epithelial cells. HCLE
cells were cultured with either SP168-derived growth culture
filtrates or medium only (control that had been previously treated
with either 100 mM of the metalloproteinase inhibitors GM6001
or TAPI-1 or their vehicle (DMSO) for 1 hour at 37uC. Culture
supernatants, analyzed by western blotting using the M11
antibody, showed a significant decrease in MUC16 shedding by
the filtrate treated with GM6001 and TAPI-1. The Y axis of the
graph represents the net intensities corresponding to MUC16
signal on western blots. Constitutive MUC16 ectodomain release
was observed in the media of control conditions (i.e. Control,
Control+DMSO, GM6001, and TAPI-1). The levels of MUC16
ectodomain release in the experimental conditions containing the
metalloproteinase inhibitors (i.e. SP168+GM6001 and
SP168+TAPI-1) were similar to those observed in the control
conditions. The mechanism(s) associated with constitutive MUC16
ectodomain shedding remains unknown.
(TIF)
Table S1 Primers used to construct the SP168 zmpC deletion
mutant.
(DOC)
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